
About CARE Ratings
CARE Ratings is a publicly listed company based in Mumbai (India) founded in 1993. Provider of independent credit ratings and assessments for businesses. The company has 636 employees. Its website careratings.com draws about 150 thousand monthly visits. Its Indian entity Care Ratings Limited reported revenue of ₹528 Cr. Its focus areas include Enterprise Applications, Data as a Service, Business and Credit Ratings. Its competitors include Acuite Ratings & Research and Corpository; 1 of its 2 listed competitors has raised funding.
Company details
CARE Ratings was founded in 1993 and is headquartered in Mumbai, India. Credit ratings and related assessments are offered to companies in various sectors, enabling corporates to access capital for operational needs. Investors are supported through insights on credit risk to inform decisions. Operations focus on independent evaluations within the financial services industry, serving domestic and select international clients.
- Headquarters Mumbai, India
- Employees 636
- Stage Public
- SectorsTechnology
- Website careratings.com
- Social LinkedIn X YouTube
- Legal Name Care Ratings Ltd
- Market Cap₹4,860 Cr
CARERATING · NSE
- Share Price₹1,611.60
-0.09% today
- Revenue₹473 Cr
FY 2025-26 · +17.6% YoY
- EBITDA₹197 Cr
Margin 41.7%
- Net Profit₹171 Cr
FY 2025-26 · +24.7% YoY
- P/E (TTM)26.8x
P/B 5.1x
- ROE20.0%
ROCE 26.1%
- Debt / Equity0.03
Interest cover 1.4x
- InvestorsCRISIL
& 1 more
- Employee Count636
Associated legal entities of CARE Ratings
CARE Ratings is associated with 6 registered companies on The Company Check; the primary company is Care Ratings Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Care Ratings Limited Listed CIN L67190MH1993PLC071691 | Active | 21 Apr 1993 | Mumbai, Maharashtra | ₹528 Cr | 571 | 10 | View details |
| Atria Wind Power (Chitradurga 2) Private Limited CIN U40106KA2016PTC093469 | Active | 21 May 2016 | Bangalore, Karnataka | ₹33.4 Cr | 6 | 2 | View details |
| Shreyas Solarfarms Limited CIN U40300GJ2015PLC082722 | Active | 27 Mar 2015 | Ahmedabad, Gujarat | ₹20.3 Cr | 3 | View details | |
| Sri Ranilakshmi Textiles Private Limited CIN U17111TZ1954PTC016262 | Active | 17 Jun 1954 | Coimbatore, Tamil Nadu | ₹41.4 Cr | 2 | View details | |
| Snowwhite Infrastructure Private Limited CIN U45400WB2007PTC114626 | Active | 26 Mar 2007 | Kolkata, West Bengal | ₹35.2 Cr | 58 | 3 | View details |
| P. D. Bajoria Tea And Agro Products Private Limited CIN U01132WB2010PTC144666 | Active | 30 Mar 2010 | Siliguri, West Bengal | ₹14.8 Cr | 31 | 2 | View details |
Apps and channels of CARE Ratings
its YouTube channel CareEdge has 4.31K subscribers and 30 videos.
Videos from CARE Ratings
The most watched videos on CARE Ratings's YouTube channel, CareEdge (4.31K subscribers). Click a video to play it here.
More on CareEdge.
Funding Insights of CARE Ratings
- Total Rounds 2
- First Round $3.68M
(Aug 2013)
- Investors Count 2
All 2 funding rounds of CARE Ratings with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | Post-IPO | – | – | ||
| Aug 2013 | $3.68M | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in CARE Ratings
CARE Ratings has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include CRISIL and Ascent Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AscentCapital is engaged in potato farming, grain marketing, and equipment services in Maine. | 2000 | ascentcapital.in | Bengaluru, India | |
Credit rating database for financial institutions, energy sectors, automobiles, and telecom | 1987 | crisil.com | Mumbai, India |
Investor details for CARE Ratings
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Care Ratings Limited (CARE Ratings)
Care Ratings Limited is the primary company behind CARE Ratings. The boards of the 6 registered companies of CARE Ratings currently have 20 directors; the longest-serving is Palanigounder Ponnusamy, appointed in 2000. 82 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Palanigounder Ponnusamy DIN 00066124 | Managing Director | 29 Sep 2000 | 26 yrs | Sri Ranilakshmi Textiles Private Limited |
| Ponnusamy Vallinayagam DIN 00066206 | Director | 28 Jun 2002 | 24 yrs 4 mo | Sri Ranilakshmi Textiles Private Limited |
| Venkatadri Chandrasekaran DIN 03126243 | Director | 15 Nov 2017 | 8 yrs 11 mo | Care Ratings Limited |
| Bharat Bahl DIN 07644015 | Director | 28 Mar 2018 | 8 yrs 7 mo | Shreyas Solarfarms Limited |
| Rishi Jalan DIN 00560652 | Director | 30 Jul 2021 | 5 yrs 2 mo | Snowwhite Infrastructure Private Limited |
| Mehul Harshadray Pandya DIN 07610232 | Managing Director | 29 Jul 2022 | 4 yrs 3 mo | Care Ratings Limited |
| Gurumoorthy Mahalingam DIN 09660723 | Director | 21 Nov 2022 | 3 yrs 11 mo | Care Ratings Limited |
| Sobhag Jain DIN 08770020 | Director | 28 Jan 2023 | 3 yrs 9 mo | Care Ratings Limited |
| Madhu Sudan Chokhani DIN 00503794 | Director | 22 Mar 2024 | 2 yrs 7 mo | Snowwhite Infrastructure Private Limited |
| Bidhan Dutta DIN 07598964 | Director | 22 Mar 2024 | 2 yrs 7 mo | P. D. Bajoria Tea And Agro Products Private Limited |
| Tanmoy Dutta DIN 10179007 | Director | 22 Mar 2024 | 2 yrs 7 mo | P. D. Bajoria Tea And Agro Products Private Limited |
| Manoj Chugh DIN 02640995 | Director | 09 May 2024 | 2 yrs 5 mo | Care Ratings Limited |
| Yelladabagi Siddabasavaiah Lathamani DIN 10888072 | Director | 27 Dec 2024 | 1 yr 10 mo | Atria Wind Power (Chitradurga 2) Private Limited |
| Nagesh Vangala DIN 00653592 | Additional Director | 06 Jan 2025 | 1 yr 9 mo | Atria Wind Power (Chitradurga 2) Private Limited |
| Nitin Sabikhi DIN 09286351 | Director | 14 Apr 2025 | 1 yr 6 mo | Shreyas Solarfarms Limited |
| Kailash Chandra Pandey DIN 11086659 | Director | 02 May 2025 | 1 yr 5 mo | Shreyas Solarfarms Limited |
| Rajiv Bansal DIN 00245460 | Director | 30 May 2025 | 1 yr 4 mo | Care Ratings Limited |
| Indrani Banerjee DIN 09043941 | Director | 30 May 2025 | 1 yr 4 mo | Care Ratings Limited |
| Bimalkumar Natvarlal Patel DIN 03006605 | Additional Director | 12 Nov 2025 | 11 mo | Care Ratings Limited |
| Nand Lal Bubna DIN 02809545 | Additional Director | 25 Nov 2025 | 11 mo | Snowwhite Infrastructure Private Limited |
People of CARE Ratings
195 people are tracked at CARE Ratings (78 in leadership, 6 in board & advisors, 111 in team); the tracked headcount is 636.
| Name | Role | Group |
|---|---|---|
Ravleen Sethi | Director And Head Corporate Ratings | Leadership |
Ritu Dalal | Assisstant Director | Leadership |
Vidhyasagar Lingesan | Rating Head | Leadership |
Divyesh B Shah | Director Ratings | Leadership |
Revati Kasture | Executive Director | Leadership |
Harsh Desai | Assistant Director (corporate Credit Rating) - MCG | Leadership |
Rohan Deshmukh | Assistant Director (large Corporate Group) | Leadership |
Maulesh Desai | Director- Corporate Ratings | Leadership |
Sanjay Agarwal | Senior Director | Leadership |
Ankit Hapani | Assistant Director- Large Corporate Group | Leadership |
Omkar Dalvi | Assistant Director Of Human Resources | Leadership |
Shivangi Sharma | Associate Director | Leadership |
Ankur Sachdeva | Senior Director Business Development | Leadership |
Ca Sanchit Agrawal | Assistant Director | Leadership |
Pradeep Kumar V | Senior Director And Business Head - BFSI | Leadership |
Thumma Sujatha | Assistant Director Business Development | Leadership |
Kunal Shah | Director - Strategy & New Initiatives | Leadership |
Saikat Roy | Business Head - Corporate & Infra | Leadership |
Padmanabh Bhagavath | Senior Director - Corporate Ratings | Leadership |
Setu Gajjar | Associate Director | Leadership |
175 more people are available in the full profile.
Complete people profiles for CARE Ratings
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of CARE Ratings
CARE Ratings is a publicly listed company on the NSE with ticker symbol CARERATING in India, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Dec 2012
- Listed onBSE: 534804 · NSE: CARERATING
- Listed entityCARE Ratings Ltd
- Exchange sectorCommercial services
- ISININE752H01013
- Share price₹1,601.60 (+5.07% on the day) · 2026-10-14
- Market capitalisation₹4,610 Cr
- Price to earnings27.2
- EPS (diluted, trailing year)₹58.93
- Dividend yield1.44%
- Volume (last session)140,006
Financials of CARE Ratings
Exchange-reported figures of Care Ratings Limited, the listed company behind CARE Ratings (NSE: CARERATING).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 473 | 402 | 332 | 279 | 248 | 248 | 244 |
| Revenue growth | +17.6% | +21.3% | +18.9% | +12.7% | -0.3% | +2.0% | - |
| EBITDA | 197 | 155 | 112 | 99.34 | 79.60 | 95.77 | 81.32 |
| EBITDA margin | +41.7% | +38.6% | +33.8% | +35.6% | +32.1% | +38.6% | +33.4% |
| Profit before tax | 235 | 192 | 147 | 126 | 98.62 | 119 | 104 |
| Net profit | 171 | 137 | 101 | 83.53 | 75.10 | 89.51 | 82.37 |
| Net profit margin | +36.2% | +34.1% | +30.3% | +29.9% | +30.3% | +36.0% | +33.8% |
| EPS (₹) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 | 27.96 |
| Balance sheet | |||||||
| Total assets | 985 | 857 | 760 | 709 | 673 | 611 | 553 |
| Net worth | 932 | 806 | 717 | 672 | 648 | 589 | 533 |
| Total debt | 26.18 | 23.77 | 19.55 | 17.48 | 8.91 | 7.23 | 0.00 |
| Cash & bank | 129 | 97.00 | 58.38 | 56.45 | 82.16 | 290 | 115 |
| Net working capital | 543 | 598 | 598 | 546 | 516 | 291 | 124 |
| Cash flow | |||||||
| Cash from operations | 148 | 123 | 90.88 | 82.24 | 68.00 | 86.17 | 67.40 |
| Cash from investing | (94.45) | (58.43) | (39.07) | 12.88 | (27.32) | (37.72) | 26.73 |
| Cash from financing | (59.33) | (54.00) | (62.96) | (63.33) | (35.14) | (43.36) | (107) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 131 | 112 | 136 | 93.91 | 110 | 96.38 | 117 |
| Revenue growth (YoY) | +18.9% | +19.2% | +16.3% | +16.2% | +19.0% | - | - | - |
| Other income | 14.80 | 15.71 | 12.99 | 12.58 | 13.70 | 15.17 | 11.85 | 11.86 |
| EBITDA | 34.63 | 60.75 | 40.34 | 68.41 | 27.74 | 47.37 | 30.43 | 55.72 |
| EBITDA margin | +31.0% | +46.5% | +36.0% | +50.2% | +29.5% | +43.2% | +31.6% | +47.5% |
| Depreciation | 3.86 | 3.83 | 3.69 | 3.46 | 3.40 | 3.06 | 3.00 | 2.85 |
| Interest | 0.60 | 0.63 | 0.65 | 0.61 | 0.60 | 0.60 | 0.56 | 0.49 |
| Profit before tax | 44.97 | 72.00 | 48.99 | 76.92 | 37.44 | 58.88 | 38.72 | 64.24 |
| Tax | 11.98 | 18.56 | 12.46 | 19.70 | 10.94 | 15.52 | 10.35 | 17.36 |
| Net profit | 32.99 | 53.44 | 36.53 | 57.22 | 26.50 | 43.36 | 28.37 | 46.88 |
| EPS (₹) | 10.70 | 17.51 | 11.91 | 18.81 | 8.56 | 14.17 | 9.30 | 15.36 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 388 | 337 | 283 | 249 | 219 | 220 | 219 |
| Revenue growth | +15.2% | +18.9% | +13.8% | +13.5% | -0.2% | +0.3% | - |
| EBITDA | 187 | 155 | 124 | 110 | 86.00 | 88.27 | 76.54 |
| EBITDA margin | +48.3% | +46.1% | +43.8% | +44.1% | +39.2% | +40.2% | +34.9% |
| Profit before tax | 232 | 197 | 162 | 138 | 107 | 113 | 100 |
| Net profit | 174 | 148 | 119 | 104 | 84.46 | 85.83 | 80.48 |
| Net profit margin | +45.0% | +44.0% | +42.2% | +41.7% | +38.5% | +39.1% | +36.7% |
| EPS (₹) | 58.04 | 49.44 | 40.01 | 34.95 | 28.49 | 29.13 | 27.32 |
| Balance sheet | |||||||
| Total assets | 1,013 | 886 | 787 | 718 | 665 | 600 | 546 |
| Net worth | 984 | 858 | 759 | 695 | 650 | 583 | 532 |
| Total debt | 15.57 | 15.71 | 16.69 | 13.65 | 4.22 | 6.49 | 0.00 |
| Cash & bank | 67.82 | 26.56 | 30.50 | 42.76 | 71.27 | 269 | 101 |
| Net working capital | 473 | 526 | 555 | 515 | 490 | 259 | 103 |
| Cash flow | |||||||
| Cash from operations | 142 | 121 | 107 | 94.51 | 63.54 | 82.47 | 65.69 |
| Cash from investing | (98.31) | (71.91) | (59.61) | (2.22) | (22.87) | (37.80) | 25.93 |
| Cash from financing | (53.07) | (52.93) | (59.96) | (61.74) | (34.59) | (42.71) | (106) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 88.15 | 108 | 90.24 | 114 | 75.64 | 91.24 | 78.59 | 102 |
| Revenue growth (YoY) | +16.5% | +17.9% | +14.8% | +12.6% | +15.8% | - | - | - |
| Other income | 15.63 | 15.39 | 13.16 | 12.54 | 14.74 | 15.51 | 11.43 | 11.76 |
| Total expenses | 56.06 | 49.68 | 53.00 | 49.30 | 48.50 | 45.49 | 48.29 | 44.60 |
| EBITDA | 32.09 | 57.90 | 37.24 | 64.97 | 27.14 | 45.75 | 30.30 | 56.91 |
| EBITDA margin | +36.4% | +53.8% | +41.3% | +56.9% | +35.9% | +50.1% | +38.6% | +56.1% |
| Depreciation | 2.33 | 2.33 | 2.30 | 2.30 | 2.09 | 1.95 | 2.01 | 1.98 |
| Interest | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.38 | 0.39 | 0.40 |
| Profit before tax | 45.02 | 70.58 | 47.71 | 74.81 | 39.38 | 58.93 | 39.33 | 66.29 |
| Tax | 11.15 | 17.20 | 11.65 | 18.98 | 10.26 | 14.04 | 9.86 | 16.66 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 131 | 112 | 136 | 93.91 | 110 | 96.38 | 117 |
| Revenue growth (YoY) | +18.9% | +19.2% | +16.3% | +16.2% | +19.0% | - | - | - |
| Other income | 14.80 | 15.71 | 12.99 | 12.58 | 13.70 | 15.17 | 11.85 | 11.86 |
| EBITDA | 34.63 | 60.75 | 40.34 | 68.41 | 27.74 | 47.37 | 30.43 | 55.72 |
| EBITDA margin | +31.0% | +46.5% | +36.0% | +50.2% | +29.5% | +43.2% | +31.6% | +47.5% |
| Depreciation | 3.86 | 3.83 | 3.69 | 3.46 | 3.40 | 3.06 | 3.00 | 2.85 |
| Interest | 0.60 | 0.63 | 0.65 | 0.61 | 0.60 | 0.60 | 0.56 | 0.49 |
| Profit before tax | 44.97 | 72.00 | 48.99 | 76.92 | 37.44 | 58.88 | 38.72 | 64.24 |
| Tax | 11.98 | 18.56 | 12.46 | 19.70 | 10.94 | 15.52 | 10.35 | 17.36 |
| Net profit | 32.99 | 53.44 | 36.53 | 57.22 | 26.50 | 43.36 | 28.37 | 46.88 |
| EPS (₹) | 10.70 | 17.51 | 11.91 | 18.81 | 8.56 | 14.17 | 9.30 | 15.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 473 | 402 | 332 | 279 | 248 | 248 | 244 |
| Revenue growth | +17.6% | +21.3% | +18.9% | +12.7% | -0.3% | +2.0% | - |
| Other income | 54.81 | 50.75 | 46.69 | 37.94 | 27.19 | 31.29 | 31.47 |
| Total expenses | 276 | 247 | 220 | 180 | 168 | 153 | 162 |
| Employee cost | 215 | 189 | 165 | 134 | 126 | 120 | 109 |
| EBITDA | 197 | 155 | 112 | 99.34 | 79.60 | 95.77 | 81.32 |
| EBITDA margin | +41.7% | +38.6% | +33.8% | +35.6% | +32.1% | +38.6% | +33.4% |
| Depreciation | 14.37 | 11.72 | 10.48 | 10.53 | 7.71 | 7.80 | 7.77 |
| Interest | 2.49 | 2.11 | 1.71 | 1.00 | 0.46 | 0.62 | 0.93 |
| Profit before tax | 235 | 192 | 147 | 126 | 98.62 | 119 | 104 |
| Tax | 61.66 | 52.26 | 44.07 | 40.29 | 21.80 | 27.68 | 20.61 |
| Net profit | 171 | 137 | 101 | 83.53 | 75.10 | 89.51 | 82.37 |
| Net profit margin | +36.2% | +34.1% | +30.3% | +29.9% | +30.3% | +36.0% | +33.8% |
| EPS (₹) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 | 27.96 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 30.05 | 29.93 | 29.85 | 29.70 | 29.65 | 29.46 | 29.46 |
| Reserves & surplus | 902 | 776 | 687 | 643 | 618 | 559 | 480 |
| Shareholders' funds (net worth) | 932 | 806 | 717 | 672 | 648 | 589 | 533 |
| Minority interest | 10.68 | 9.23 | 7.46 | 6.83 | 5.31 | 4.22 | 3.25 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 26.18 | 23.77 | 19.55 | 17.48 | 8.91 | 7.23 | 0.00 |
| Total debt | 26.18 | 23.77 | 19.55 | 17.48 | 8.91 | 7.23 | 0.00 |
| Total liabilities | 985 | 857 | 760 | 709 | 673 | 611 | 553 |
| Assets | |||||||
| Gross block | 163 | 157 | 140 | 132 | 115 | 102 | 106 |
| Net block | 122 | 119 | 109 | 107 | 95.62 | 85.07 | 93.11 |
| Capital work in progress | 5.32 | 2.92 | 5.99 | 4.23 | 8.19 | 3.15 | 0.52 |
| Investments | 86.88 | 134 | 43.82 | 43.91 | 44.00 | 240 | 339 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 35.04 | 32.09 | 22.49 | 21.51 | 16.64 | 21.36 | 40.89 |
| Cash & bank balances | 129 | 97.00 | 58.38 | 56.45 | 82.16 | 290 | 115 |
| Loans & advances | 493 | 563 | 594 | 525 | 465 | 29.53 | 27.94 |
| Total current assets | 657 | 692 | 675 | 603 | 564 | 341 | 183 |
| Total current liabilities | 113 | 94.53 | 76.26 | 57.02 | 47.96 | 50.15 | 59.82 |
| Net working capital | 543 | 598 | 598 | 546 | 516 | 291 | 124 |
| Total assets | 985 | 857 | 760 | 709 | 673 | 611 | 553 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 48.82 | 38.29 | 49.42 | 17.63 | 12.09 | 6.99 | 19.82 |
| Net cash from operating activities | 148 | 123 | 90.88 | 82.24 | 68.00 | 86.17 | 67.40 |
| Net cash from investing activities | (94.45) | (58.43) | (39.07) | 12.88 | (27.32) | (37.72) | 26.73 |
| Net cash from financing activities | (59.33) | (54.00) | (62.96) | (63.33) | (35.14) | (43.36) | (107) |
| Net change in cash | (6.22) | 10.53 | (11.14) | 31.79 | 5.55 | 5.09 | (12.83) |
| Closing cash | 129 | 97.00 | 58.38 | 56.45 | 82.16 | 290 | 115 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +17.6% | +21.3% | +18.9% | +12.7% | -0.3% | +2.0% | - |
| EBITDA growth | +27.1% | +38.6% | +12.9% | +24.8% | -16.9% | +17.8% | - |
| PBT growth | +22.4% | +31.1% | +16.6% | +27.5% | -16.9% | +14.0% | -48.4% |
| Net income growth | +24.7% | +36.6% | +20.3% | +11.2% | -16.1% | +8.7% | - |
| Revenue CAGR (3Y) | +19.3% | +17.6% | +10.1% | +4.6% | -8.1% | -9.3% | -5.4% |
| EBITDA CAGR (3Y) | +25.7% | +25.0% | +5.4% | +6.9% | -23.0% | -23.1% | -23.6% |
| Profitability & leverage | |||||||
| Net income margin | +36.7% | +34.8% | +30.9% | +30.6% | +31.0% | +36.6% | +34.3% |
| Return on capital employed | +26.1% | +24.3% | +20.4% | +18.5% | +15.5% | +20.6% | +19.0% |
| Return on net worth | +20.0% | +18.4% | +14.8% | +13.0% | +12.4% | +16.2% | +15.4% |
| Debt / equity | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Long-term debt / equity | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| Interest cover | 1.36 | 1.47 | 1.68 | 1.13 | 0.64 | 0.70 | 1.26 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.96 | 2.71 | 2.44 | 2.26 | 2.29 | 2.39 | 2.46 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 14.09 | 14.74 | 15.47 | 15.07 | 13.03 | 7.98 | 5.53 |
| EPS (₹) | 56.97 | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 | 27.96 |
| Dividend per share (₹) | 22.00 | 18.00 | 18.00 | 25.00 | 17.00 | 17.00 | 19.50 |
| Book value per share (₹) | 310.29 | 269.37 | 240.23 | 226.33 | 218.41 | 199.86 | 173.02 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 88.15 | 108 | 90.24 | 114 | 75.64 | 91.24 | 78.59 | 102 |
| Revenue growth (YoY) | +16.5% | +17.9% | +14.8% | +12.6% | +15.8% | - | - | - |
| Other income | 15.63 | 15.39 | 13.16 | 12.54 | 14.74 | 15.51 | 11.43 | 11.76 |
| Total expenses | 56.06 | 49.68 | 53.00 | 49.30 | 48.50 | 45.49 | 48.29 | 44.60 |
| EBITDA | 32.09 | 57.90 | 37.24 | 64.97 | 27.14 | 45.75 | 30.30 | 56.91 |
| EBITDA margin | +36.4% | +53.8% | +41.3% | +56.9% | +35.9% | +50.1% | +38.6% | +56.1% |
| Depreciation | 2.33 | 2.33 | 2.30 | 2.30 | 2.09 | 1.95 | 2.01 | 1.98 |
| Interest | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.38 | 0.39 | 0.40 |
| Profit before tax | 45.02 | 70.58 | 47.71 | 74.81 | 39.38 | 58.93 | 39.33 | 66.29 |
| Tax | 11.15 | 17.20 | 11.65 | 18.98 | 10.26 | 14.04 | 9.86 | 16.66 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 388 | 337 | 283 | 249 | 219 | 220 | 219 |
| Revenue growth | +15.2% | +18.9% | +13.8% | +13.5% | -0.2% | +0.3% | - |
| Other income | 55.68 | 51.39 | 46.96 | 37.10 | 28.36 | 32.12 | 31.34 |
| Total expenses | 200 | 182 | 159 | 139 | 133 | 131 | 143 |
| Employee cost | 163 | 146 | 125 | 104 | 107 | 103 | 96.70 |
| EBITDA | 187 | 155 | 124 | 110 | 86.00 | 88.27 | 76.54 |
| EBITDA margin | +48.3% | +46.1% | +43.8% | +44.1% | +39.2% | +40.2% | +34.9% |
| Depreciation | 9.02 | 7.94 | 7.65 | 8.05 | 6.99 | 7.09 | 6.91 |
| Interest | 1.59 | 1.58 | 1.48 | 0.70 | 0.40 | 0.57 | 0.74 |
| Profit before tax | 232 | 197 | 162 | 138 | 107 | 113 | 100 |
| Tax | 58.08 | 49.02 | 42.44 | 34.34 | 22.51 | 26.90 | 19.75 |
| Net profit | 174 | 148 | 119 | 104 | 84.46 | 85.83 | 80.48 |
| Net profit margin | +45.0% | +44.0% | +42.2% | +41.7% | +38.5% | +39.1% | +36.7% |
| EPS (₹) | 58.04 | 49.44 | 40.01 | 34.95 | 28.49 | 29.13 | 27.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 30.05 | 29.93 | 29.85 | 29.70 | 29.65 | 29.46 | 29.46 |
| Reserves & surplus | 954 | 828 | 729 | 665 | 621 | 554 | 479 |
| Shareholders' funds (net worth) | 984 | 858 | 759 | 695 | 650 | 583 | 532 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 15.57 | 15.71 | 16.69 | 13.65 | 4.22 | 6.49 | 0.00 |
| Total debt | 15.57 | 15.71 | 16.69 | 13.65 | 4.22 | 6.49 | 0.00 |
| Total liabilities | 1,013 | 886 | 787 | 718 | 665 | 600 | 546 |
| Assets | |||||||
| Gross block | 127 | 128 | 120 | 113 | 99.35 | 91.72 | 94.04 |
| Net block | 91.80 | 92.81 | 92.98 | 90.85 | 81.95 | 76.34 | 82.63 |
| Capital work in progress | 4.89 | 2.92 | 1.47 | 2.86 | 6.52 | 3.74 | 0.34 |
| Investments | 207 | 255 | 129 | 112 | 70.51 | 266 | 359 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 25.43 | 22.48 | 14.71 | 15.19 | 13.61 | 16.69 | 36.02 |
| Cash & bank balances | 67.82 | 26.56 | 30.50 | 42.76 | 71.27 | 269 | 101 |
| Loans & advances | 470 | 553 | 568 | 500 | 443 | 14.68 | 17.62 |
| Total current assets | 563 | 602 | 614 | 558 | 528 | 300 | 155 |
| Total current liabilities | 89.95 | 76.34 | 58.33 | 42.74 | 37.31 | 40.96 | 51.34 |
| Net working capital | 473 | 526 | 555 | 515 | 490 | 259 | 103 |
| Total assets | 1,013 | 886 | 787 | 718 | 665 | 600 | 546 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 26.35 | 30.29 | 42.51 | 11.96 | 5.88 | 3.93 | 18.33 |
| Net cash from operating activities | 142 | 121 | 107 | 94.51 | 63.54 | 82.47 | 65.69 |
| Net cash from investing activities | (98.31) | (71.91) | (59.61) | (2.22) | (22.87) | (37.80) | 25.93 |
| Net cash from financing activities | (53.07) | (52.93) | (59.96) | (61.74) | (34.59) | (42.71) | (106) |
| Net change in cash | (9.07) | (3.94) | (12.22) | 30.55 | 6.08 | 1.95 | (14.40) |
| Closing cash | 67.82 | 26.56 | 30.50 | 42.76 | 71.27 | 269 | 101 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +15.2% | +18.9% | +13.8% | +13.5% | -0.2% | +0.3% | - |
| EBITDA growth | +20.8% | +25.1% | +13.0% | +27.7% | -2.6% | +15.3% | - |
| PBT growth | +18.0% | +21.7% | +17.2% | +29.1% | -5.1% | +12.5% | -49.4% |
| Net income growth | +17.8% | +23.9% | +15.1% | +22.9% | -1.6% | +6.7% | - |
| Revenue CAGR (3Y) | +15.9% | +15.4% | +8.8% | +4.3% | -9.7% | -11.9% | -7.9% |
| EBITDA CAGR (3Y) | +19.5% | +21.7% | +12.0% | +12.8% | -20.5% | -25.0% | -25.6% |
| Profitability & leverage | |||||||
| Net income margin | +45.0% | +44.0% | +42.2% | +41.7% | +38.5% | +39.1% | +36.7% |
| Return on capital employed | +24.7% | +23.7% | +21.7% | +20.1% | +17.0% | +19.8% | +18.3% |
| Return on net worth | +18.9% | +18.3% | +16.4% | +15.4% | +13.7% | +15.4% | +14.9% |
| Debt / equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Long-term debt / equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.89 | 1.07 | 1.27 | 0.69 | 0.51 | 0.70 | 1.06 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.04 | 2.71 | 2.43 | 2.35 | 2.30 | 2.36 | 2.47 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 16.19 | 18.11 | 18.93 | 17.28 | 14.47 | 8.33 | 5.51 |
| EPS (₹) | 58.04 | 49.44 | 40.01 | 34.95 | 28.49 | 29.13 | 27.32 |
| Dividend per share (₹) | 22.00 | 18.00 | 18.00 | 25.00 | 17.00 | 17.00 | 19.50 |
| Book value per share (₹) | 327.36 | 286.60 | 254.34 | 233.96 | 219.33 | 197.98 | 172.45 |
Timeline of CARE Ratings
4 dated milestones of CARE Ratings across 24 years, from founding to its latest funding, stage changes and deals.
- Founded CARE Ratings is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $3.7M.
- Funding Latest funding round, Post-IPO,.
Competitors of CARE Ratings
CARE Ratings has 2 listed competitors in our database, 1 of them funded. They include Acuite Ratings & Research and Corpository.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| acuite.in | 2005 | Mumbai, India | 165 | Credit rating data is supplied to the investment industry. | ||
| corpository.com | 2015 | Ahmedabad, India | $1.58M | 213 | Offers a web-based platform for accessing and managing corporate information. |
Detailed competitors of CARE Ratings
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CARE Ratings
The website of CARE Ratings (careratings.com) receives about 150.1K visits a month.
- Monthly visits150.1K
▼ 1.2% vs previous month
Websites whose visitors overlap most with CARE Ratings. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| icra.in | 100% | 171K | #274,567 | View details | |
| crisil.com | 97% | 443.3K | #125,844 | View details | |
| crisilratings.com | 85% | 200K | #260,054 | View details | |
| indiaratings.co.in | 81% | 69.5K | #585,734 | View details | |
| infomerics.com | 74% | 18.8K | #920,672 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for CARE Ratings
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Investment & Financial Technology
2 companies that operate in the same segment as CARE Ratings (Investment & Financial Technology) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
App-based brokerage stock trading platform | 1996 | Mumbai, Maharashtra, India | USD 38.41 M | USD 548.9 M | 3,830 | |
Smart investment portfolios are offered via an online platform. | 2015 | Bengaluru, Karnataka, India | USD 121.05 M | USD 635.51 K | 231 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Care Ratings
Complete news archive for CARE Ratings
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CARE Ratings
CARE Ratings was founded in 1993 and raised its 1st funding round 20 years after it was founded.
CARE Ratings is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
CARE Ratings has 636 employees.
The primary company behind CARE Ratings, Care Ratings Limited, reported revenue of ₹528 Cr for FY 2026, up 18% year on year.
CARE Ratings was founded in 1993 and is headquartered in Mumbai, India. Credit ratings and related assessments are offered to companies in various sectors, enabling corporates to access capital for operational needs. Investors are supported through insights on credit risk to inform decisions. Operations focus on independent evaluations within the financial services industry, serving domestic and select international clients.
CARE Ratings's top competitors include Corpository and Acuite Ratings & Research.
Yes, CARE Ratings is publicly traded on NSE under the ticker symbol CARERATING.
CARE Ratings has 2 investors. Key investors include CRISIL, and Ascent Capital.
CARE Ratings is associated with 6 legal entities: Care Ratings Limited, Shreyas Solarfarms Limited, Atria Wind Power (Chitradurga 2) Private Limited and others.
The legal entities of CARE Ratings currently have 22 directors, including Bharat Bahl, Nitin Sabikhi, Kailash Chandra Pandey and others.
The website of CARE Ratings receives about 150 thousand visits a month.
